Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

ClinicalTrials.gov ID: NCT01121484

Public ClinicalTrials.gov record NCT01121484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A multicenter, 10-week study to evaluate the efficacy and safety of 50 mg of desvenlafaxine succinate sustained-release formulation (DVS SR) versus placebo in the treatment of peri- and postmenopausal women with major depressive disorder

Study identification

NCT ID
NCT01121484
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
439 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jun 2011 (Actual)
Last update posted
Apr 4, 2012

2010 – 2011

United States locations

U.S. sites
44
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Little Rock Arkansas 72223 —
Pacific Clinical Research Medical Group Arcadia California 91007-3462 —
Southwestern Research, Inc. Beverly Hills California 90210 —
Catalina Research Institute LLC Chino California 91710 —
Pacific Clinical Research Medical Group Orange California 92868 —
Pacific Clinical Research Medical Group Upland California 91786 —
Western Affiliated Research Institute Denver Colorado 80209 —
Radiant Research, Inc. Denver Colorado 80239 —
Connecticut Clinical Research Cromwell Connecticut 06416 —
Comprehensive NeuroScience, Inc. St. Petersburg Florida 33716 —
Stedman Clinical Trials, LLC Tampa Florida 33613 —
Janus Center for Psychiatric Research West Palm Beach Florida 33407 —
Emory University Department of Psychiatry and Behavioral Sciences Atlanta Georgia 30306 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Northwest Behavioral Research Center Roswell Georgia 30076 —
Carman Research Smyrna Georgia 30080 —
Capstone Clinical Research Libertyville Illinois 60048 —
Deaconess Clinic Gateway Health Center Research Institute Newburgh Indiana 47630 —
Via Christi Research Witchita Kansas 67214 —
Westside Family Medical Center, P.C. Kalamazoo Michigan 49009 —
Radiant Research, Inc. Las Vegas Nevada 89146 —
Center For Emotional Fitness Cherry Hill New Jersey 08002 —
Robert Wood Johnson Medical School Piscataway New Jersey 08854 —
Social Psychiatry Research Institute Brooklyn New York 11235 —
Medical & Behavioral Health Research PC New York New York 10023 —
Metrolina Medical Research Charlotte North Carolina 28209 —
Horizon Medical Services, PC Bismarck North Dakota 58501 —
Legacy Pharma Research Bismarck North Dakota 58501 —
North Coast Clinical Trials, Inc. Beechwood Ohio 44122 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Summit Research Network (Oregon), Inc. Portland Oregon 97210 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
Omega Medical Research Warwick Rhode Island 02886 —
Carolina Clinical Research Services, LLC Columbia South Carolina 29201 —
Holston Medical Group Bristol Tennessee 37620 —
Holston Medical Group Kingsport Tennessee 37660 —
Bayou City Research, Ltd. Houston Texas 77007 —
Radiant Research, Inc. San Antonio Texas 78229 —
University of Virginia Health System Center for Psychiatric Clinical Research Charlottesville Virginia 22903 —
Nelson Clinic Richmond Virginia 23298 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Summit Research Network (Seattle) LLC Seattle Washington 98104 —
Independent Psychiatric Consultants, SC dba IPC Research Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01121484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2012 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01121484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →